专利检索 ap:("Global Blood Therapeutics, Inc.") AND inv:"Eleanor L. Ramos" 第 1 页

1.

发明申请
DOSING REGIMENS FOR 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE 有权

公开(公告)号：US20220378770A1

公开(公告)日：2022-12-01

申请号：US17881874

申请日：2022-08-05

申请人： Global Blood Therapeutics, Inc.

发明人： Eleanor L. Ramos , Joshua Eli Lehrer-Graiwer , Athiwat Hutchaleelaha , Naveen Bejugam

IPC分类号： A61K31/4439 , A61K9/16 , A61K9/48

摘要： Provided herein are methods for treating sickle cell disease, comprising administering to a subject 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)-methoxy)benzaldehyde (Compound 1), or a polymorph thereof, in certain dosing regimens.

2.

发明授权
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde 有权

公开(公告)号：US11020382B2

公开(公告)日：2021-06-01

申请号：US15368142

申请日：2016-12-02

申请人： Global Blood Therapeutics, Inc.

发明人： Eleanor L. Ramos , Joshua Eli Lehrer-Graiwer , Athiwat Hutchaleelaha

IPC分类号： A61K31/4439 , A61K9/16 , A61K9/48

摘要： Provided herein are methods for treating sickle cell disease, comprising administering to a subject 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)-methoxy)benzaldehyde (Compound 1), or a polymorph thereof, in certain dosing regimens.

3.

发明申请
DOSING REGIMENS FOR 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE 审中-公开

公开(公告)号：US20170157101A1

公开(公告)日：2017-06-08

申请号：US15368142

申请日：2016-12-02

申请人： Global Blood Therapeutics, Inc.

发明人： Eleanor L. Ramos , Joshua Eli Lehrer-Graiwer , Athiwat Hutchaleelaha

IPC分类号： A61K31/4439 , A61K9/48

CPC分类号： A61K31/4439 , A61K9/1605 , A61K9/4858 , A61K9/4866

摘要： Provided herein are methods for treating sickle cell disease, comprising administering to a subject 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)-methoxy)benzaldehyde (Compound 1), or a polymorph thereof, in certain dosing regimens.

4.

发明授权
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde 有权

公开(公告)号：US11944612B2

公开(公告)日：2024-04-02

申请号：US17881874

申请日：2022-08-05

申请人： Global Blood Therapeutics, Inc.

发明人： Eleanor L. Ramos , Joshua Eli Lehrer-Graiwer , Athiwat Hutchaleelaha , Naveen Bejugam

IPC分类号： A61K31/4439 , A61K9/16 , A61K9/48

CPC分类号： A61K31/4439 , A61K9/1605 , A61K9/4858 , A61K9/4866

摘要： Provided herein are methods for treating sickle cell disease, comprising administering to a subject 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)-methoxy)benzaldehyde (Compound 1), or a polymorph thereof, in certain dosing regimens.

5.

发明申请
DOSING REGIMENS FOR 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE 有权

公开(公告)号：US20220110928A1

公开(公告)日：2022-04-14

申请号：US17559156

申请日：2021-12-22

申请人： Global Blood Therapeutics, Inc.

发明人： Eleanor L. Ramos , Joshua Eli Lehrer-Graiwer , Athiwat Hutchaleelaha , Naveen Bejugam

IPC分类号： A61K31/4439 , A61K9/16 , A61K9/48

摘要： Provided herein are methods for treating sickle cell disease, comprising administering to a subject 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)-methoxy)benzaldehyde (Compound 1), or a polymorph thereof, in certain dosing regimens.

6.

发明申请
DOSING REGIMENS FOR 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE 有权

公开(公告)号：US20210267956A1

公开(公告)日：2021-09-02

申请号：US17326045

申请日：2021-05-20

申请人： Global Blood Therapeutics, Inc.

发明人： Eleanor L. Ramos , Joshua Eli Lehrer-Graiwer , Athiwat Hutchaleelaha , Naveen Bejugam

IPC分类号： A61K31/4439 , A61K9/16 , A61K9/48

摘要： Provided herein are methods for treating sickle cell disease, comprising administering to a subject 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)-methoxy)benzaldehyde (Compound 1), or a polymorph thereof, in certain dosing regimens.